Related references
Note: Only part of the references are listed.Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment
Laura D. Wood et al.
GASTROENTEROLOGY (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models
Gang Yang et al.
CLINICAL CANCER RESEARCH (2021)
Deubiquitylation and stabilization of Notch1 intracellular domain by ubiquitin-specific protease 8 enhance tumorigenesis in breast cancer
Soyeon Shin et al.
CELL DEATH AND DIFFERENTIATION (2020)
Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study
Suneel D. Kamath et al.
ONCOLOGIST (2020)
Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210
Zhiyong Yang et al.
CELLULAR ONCOLOGY (2020)
p62 promotes bladder cancer cell growth by activating KEAP1/NRF2-dependent antioxidative response
Tao Li et al.
CANCER SCIENCE (2020)
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
Silpa Narayanan et al.
DRUG RESISTANCE UPDATES (2020)
HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling
Yunjiang Zhou et al.
REDOX BIOLOGY (2020)
Dissenting degradation: Deubiquitinases in cell cycle and cancer
Thomas Bonacci et al.
SEMINARS IN CANCER BIOLOGY (2020)
The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway
Liam Baird et al.
MOLECULAR AND CELLULAR BIOLOGY (2020)
LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes
Cefan Zhou et al.
MOLECULAR CANCER (2020)
Deubiquitinase USP29 promotes gastric cancer cell migration by cooperating with phosphatase SCP1 to stabilize Snail protein
Wenli Qian et al.
ONCOGENE (2020)
Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway
Yunjiang Zhou et al.
REDOX BIOLOGY (2019)
Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer
Li Wei et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage
Asmi Chakraborty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
NRF2 and the Hallmarks of Cancer
Montserrat Rojo de la Vega et al.
CANCER CELL (2018)
USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization
Chenming Wu et al.
CELL DEATH AND DIFFERENTIATION (2018)
Ubiquitination: Friend and foe in cancer
Mohammed A. Mansour
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
The ubiquitin-specific protease USP8 deubiquitinates and stabilizes Cx43
Jian Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway
Chao Yu et al.
THERANOSTICS (2018)
Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer
Jia Fan et al.
THERANOSTICS (2018)
USP8 suppresses death receptor-mediated apoptosis by enhancing FLIPL stability
M. Jeong et al.
ONCOGENE (2017)
Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance
Youngtae Jeong et al.
CANCER DISCOVERY (2017)
USP39 promotes colorectal cancer growth and metastasis through the Wnt/β-catenin pathway
Xianwen Yuan et al.
ONCOLOGY REPORTS (2017)
Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
Jong-Lyel Roh et al.
REDOX BIOLOGY (2017)
Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells
S. Calabretta et al.
ONCOGENE (2016)
Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters
Xupeng Bai et al.
DRUG METABOLISM REVIEWS (2016)
Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment
Kishore Polireddy et al.
JOURNAL OF CANCER (2016)
Gemcitabine resistance in pancreatic ductal adenocarcinoma
Yoav Binenbaum et al.
DRUG RESISTANCE UPDATES (2015)
Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness
Wareeporn Wattanawongdon et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Ubiquitination in disease pathogenesis and treatment
Doris Popovic et al.
NATURE MEDICINE (2014)
Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration
Ning Xiao et al.
BIOCHEMICAL JOURNAL (2012)
Share Paper
